136 related articles for article (PubMed ID: 21552020)
1. Outpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedure.
Willegaignon J; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
Clin Nucl Med; 2011 Jun; 36(6):440-5. PubMed ID: 21552020
[TBL] [Abstract][Full Text] [Related]
2. Commentary on Willegaignon et al.: outpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedure.
Marcus CS
Clin Nucl Med; 2011 Jun; 36(6):446. PubMed ID: 21552021
[No Abstract] [Full Text] [Related]
3. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
[TBL] [Abstract][Full Text] [Related]
4. Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy.
Kusakabe K; Yokoyama K; Ito K; Shibuya H; Kinuya S; Ito M; Higashi T; Togawa T; Koizumi K; Yoshimura M; Uchiyama M; Okamoto T; Kanaya S; Kanaya K; Yoneyama T; Ikebuchi H; Yanagida S; Shibata K; Segawa K; Yamamoto A
Ann Nucl Med; 2012 May; 26(4):370-8. PubMed ID: 22450825
[TBL] [Abstract][Full Text] [Related]
5. Outpatient therapeutic 131I for thyroid cancer.
Panzegrau B; Gordon L; Goudy GH
J Nucl Med Technol; 2005 Mar; 33(1):28-30. PubMed ID: 15731017
[TBL] [Abstract][Full Text] [Related]
6. Radiation doses to cohabitants of patients undergoing radioiodine ablation for thyroid cancer: poor compliance with radiation protection guidelines but low radiation exposure.
Gabriel S; Farman-Ara B; Bourrelly M; Carpentier O; Sebag F; Palazzo FF; De Micco C; Mancini J; Henry JF; Mundler O; Taïeb D
Nucl Med Commun; 2011 Sep; 32(9):829-33. PubMed ID: 21633315
[TBL] [Abstract][Full Text] [Related]
7. Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review.
Al-Shakhrah IA
Clin J Oncol Nurs; 2008 Dec; 12(6):905-12. PubMed ID: 19064384
[TBL] [Abstract][Full Text] [Related]
8. Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy.
Parthasarathy KL; Crawford ES
J Nucl Med Technol; 2002 Dec; 30(4):165-71; quiz 172-3. PubMed ID: 12446749
[TBL] [Abstract][Full Text] [Related]
9. Patient parameters and other radiation safety issues in 131I therapy for thyroid cancer treatment.
Al-Haj AN; Lagarde CS; Lobriguito AM
Health Phys; 2007 Dec; 93(6):656-66. PubMed ID: 17993846
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry and thyroid cancer: the individual dosage of radioiodine.
Lassmann M; Reiners C; Luster M
Endocr Relat Cancer; 2010 Sep; 17(3):R161-72. PubMed ID: 20448022
[TBL] [Abstract][Full Text] [Related]
11. Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy.
Jeong KH; Jung JW; Kim CB; Ahn BC; Lee HK; Yoo SJ; Day O; Lee JK
Health Phys; 2014 Apr; 106(4):466-74. PubMed ID: 24562067
[TBL] [Abstract][Full Text] [Related]
12. Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy.
Marriott CJ; Webber CE; Gulenchyn KY
Radiat Prot Dosimetry; 2007; 123(1):62-7. PubMed ID: 16825250
[TBL] [Abstract][Full Text] [Related]
13. Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma.
Hänscheid H; Lassmann M; Luster M; Kloos RT; Reiners C
Endocr Relat Cancer; 2009 Dec; 16(4):1283-9. PubMed ID: 19628649
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the blood picture after radioiodine therapy of thyroid cancer].
Grünwald F; Schomburg A; Menzel C; Steinecker S; Späth G; Bockisch A; Fimmers R; Hotze AL; Biersack HJ
Med Klin (Munich); 1994 Oct; 89(10):522-8. PubMed ID: 7808352
[TBL] [Abstract][Full Text] [Related]
15. [Effective focal doses and the radiation loads in the radioiodine therapy of thyroid cancer].
Ivanitskaia VI; Shantyr' VI; Pudovkina LF; Kozhukhov VD
Med Radiol (Mosk); 1981 Nov; 26(11):6-12. PubMed ID: 7332697
[No Abstract] [Full Text] [Related]
16. [Environmental radiation exposure of a thyroid cancer patient resulting from adjuvant iodine radiotherapy].
Chaś J; Kowalczyk A; Siekierzyński M; Dziuk E; Janiak MK
Wiad Lek; 2001; 54 Suppl 1():312-20. PubMed ID: 12182042
[TBL] [Abstract][Full Text] [Related]
17. Thyroid remnant dose: 124I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancer.
Freudenberg LS; Frömke C; Petrich T; Marlowe RJ; Koska WW; Brandau W; Eising EG; Knust EJ; Bockisch A; Jentzen W
Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):393-9. PubMed ID: 19856257
[TBL] [Abstract][Full Text] [Related]
18. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of high-dosage radioiodine therapy in the elimination of remnant tissue following total thyroidectomy].
Schümichen C; Bulczak-Schmidt M; Blattmann H; Pauli-Harnasch C
Nuklearmedizin; 1984 Oct; 23(5):265-9. PubMed ID: 6522276
[TBL] [Abstract][Full Text] [Related]
20. [Dosimetric measurements and early complications in patients with differentiated thyroid carcinomas treated with radioactive iodine].
Malesević M; Stefanović L; Adzić O; Mihoci Z; Elez D
Med Pregl; 1992; 45(11-12):427-31. PubMed ID: 1344442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]